Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patients at least 18 years of age with moderate to severe active RA for at least 6 months;
inadequate response to current anti-rheumatic therapies, including 1 or more traditional DMARDs;
stable DMARD therapy for at least 8 weeks before entering study;
patients of reproductive potential must be using reliable methods of contraception.
You may not be if
major surgery (including joint surgery) within 8 weeks before entering study, or planned surgery within 6 months after entering study;
patients who have previously failed treatment with an anti-tumor necrosis factor agent;
women who are pregnant or breast-feeding.
Clareo Health | A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
